Importance of microbial colonization of the gut in early life to the development of immunity

https://doi.org/10.1016/j.mrfmmm.2007.03.011Get rights and content

Abstract

The mammalian gastrointestinal tract harbors a complex microbiota consisting of between 500 and 1000 distinct microbial species. Comparative studies based on the germ-free gut have provided clear evidence that the gut microbiota is instrumental in promoting the development of both the gut and systemic immune systems. Early microbial exposure of the gut is thought to dramatically reduce the incidence of inflammatory, autoimmune and atopic diseases further fuelling the scientific viewpoint, that microbial colonization plays an important role in regulating and fine-tuning the immune system throughout life. Recent molecular diversity studies have provided additional evidence that the human gut microbiota is compositionally altered in individuals suffering from inflammatory bowel disorders, suggesting that specific bacterial species are important to maintaining immunological balance and health. New and exciting insights into how gut bacteria modulate the mammalian immune system are emerging. However, much remains to be elucidated about how commensal bacteria influence the function of cells of both the innate and adaptive immune systems in health and disease.

Introduction

The human gut microbiota, shaped by the long co-evolutionary history of symbiotic host–microbe interaction, plays an important role in maintaining human health by preventing colonization by pathogens, degrading dietary and in situ-produced compounds, producing nutrients, and maintaining the normal mucosal immunity [1], [2], [3]. Other important functions have begun to emerge over recent years suggesting that the effects of the commensal microbiota may be more profound; influencing processes as complex as lipid metabolism of the host [4], predisposition to obesity [5], [6], immune development and homeostasis, inflammation, repair and angiogenesis [7], [8], [9], [10]. The inter-relationships between the microbiota and the host are clearly important in relation to health and imbalance between these systems appears to drive a wide range of mucosal and systemic immune-mediated disorders including inflammatory bowel diseases, autoimmune and allergic conditions. In this review we discuss current data linking the human commensal microbiota to immunological development and function and highlight the potential consequences of microbe–host dialogue in early life to human health.

Section snippets

A single mucosal immune system, innate and adaptive components

The mucosal immune system relies on cells of both the innate and adaptive immune systems that function concertedly to neutralize potentially dangerous infectious agents and maintain tolerance to dietary antigens and commensal bacteria [11]. Innate immune signalling is mediated by innate or natural immune cells expressing germ-line receptors of limited repertoires that respond promptly following pattern recognition of bacterial structures (pathogen-associated molecular patterns or PAMPs) and

Describing the human gut microbiota

Historically, culture-based techniques characterizing microbial diversity dominated the field and as a result the most predominant species isolated from the human gut were considered to be Bacteroides spp., Bifidobacterium spp., Eubacterium spp., Peptostreptococcus spp., and Fusobacterium spp. [13]. These techniques, essentially based on fecal sampling and plating on specific selective media under anaerobic (up to 99.9% of colonic bacteria are obligate anaerobes) and aerobic conditions

Early colonization of the GIT

The mammalian fetal intestine is essentially sterile and the first exposure to maternal microbiota occurs during passage through the birth canal during the first hours of delivery. In the beginning of colonization, the microbiota of the newborn is heterogeneous [23]. In the cultivated microbiota of vaginally delivered and breast-fed infants, the majority of the fecal population is represented by bifidobacteria, with smaller numbers of Escherichia coli, bacteroides and clostridia [24]. In

Genomic and metagenomic approaches to functionality of the human microbiota

The major drawback of descriptive microbial diversity studies is their limited value in discerning the functional role of the majority of bacteria in the human gut. To address this several new approaches have been proposed. The human gut microbiome initiative, which aims to generate draft genome sequences of hundreds of gut bacteria as well as new metagenomic analyses have been proposed as routes of analysing the functional diversity of the human gut microbiota [40], [41]. Studies utilizing

Microbial colonization and development of immunity

Extensive intercellular signalling between lymphoid cell types is a key feature of a highly regulated innate and adaptive immune system. These interactions occur within germinal centres (GCs) and secondary lymphoid follicles (LFs) associated with the structurally complex gut-associated lymphoid tissues (GALT). There is increasing awareness that the GALT plays a role in shaping the repertoire of the gut microbiota and vice versa. In young mammals GC and LF regions of the GALT are incompletely

Microbial colonization, gut barrier and maintenance of immune tolerance

Several lines of evidence from various animal and disease models support the view that there is intensive communication between the host and gut bacteria. The net outcome of this communication, in immunological terms, is dictated largely by the nature of the bacterium. In healthy individuals commensal non-harmful bacteria induce immunological tolerance, contrasting with the response generated by pathogenic bacteria, which is characterized by strong pro-inflammatory reactions that trigger immune

The IgA barrier—milk and B1 cells in young mammals

The presence of microbial-reactive IgA in the lumen strongly augments the physical barrier function of the developing and adult gut and plays a key role in shaping the immune response to microbial colonization. The intestinal IgA shields the commensal flora from both the innate and the systemic immune system [49]. This function is likely to be very critical in early life when mechanisms of immune regulation are not fully operational. In the absence of IgA, gut commensal bacteria overgrow, have

IgA barrier—T cell-dependent

In the maturing gut, high affinity neutralising IgA is generated in a T cell-dependent fashion within the organised follicular structures of the GALT. The major inductive sites in the small intestine are LFs, either solitary or clustered as in Peyer's patches (PP). These follicles are covered by a specialised follicle associated epithelium (FAE) containing M cells (microfold cells) that take up intact macromolecules, particles and pathogens, and deliver them by transepithelial transport to

Commensal bacteria, signalling through extra- and intra-cellular recognition receptors

Although exclusion and immune suppression are key features of immune tolerance to commensal bacteria, the expansion and function of the immune system is built upon recognition and sampling. These later events are critical for immune education. A wide range of TLRs [67] and non-TLRs [68] for PAMP recognition have been characterised on gut epithelial cells, associated DCs, monocytes and macrophages [69]; lineages involved in microbial-immune surveillance. Yet there is a paradox, the commensal

DCs and mesenteric lymph nodes in microbe/host interaction

The development of the GALT sees an increasingly vital sentinel role for cellular components of the innate system including DCs, macrophages and epithelial cells that together monitor the microbial environment and coordinate immune responses to danger signals [80]. A subpopulation of DCs (CX3CR1+) populate the entire lamina propria as well as the dome regions of the PP [81]. These DCs are responsible for continuous antigen acquisition from the intestinal lumen and transport of this antigen for

Tregs and mucosal tolerance

In the steady state, prior to acute infection and inflammation, DCs are in an immature state and not fully differentiated to carry out their known roles as inducers of immunity. However, these immature cells are not inactive. They continuously circulate through tissues and into lymphoid organs, capturing self-antigens as well as innocuous environmental and microbial proteins. Recent experiments have provided direct evidence of antigen-loaded immature DCs in vivo that silence T cells either by

Childhood infections and vaccination

Vaccination is the most effective means of preventing infectious diseases and is largely responsible for the eradication of diseases such as polio-myelitis, smallpox and diphtheria that, in early periods of history, caused high mortality amongst children. Whilst disease control in this way is absolutely essential much of the ongoing work in vaccine development aims to derive ‘good vaccines’ with improved biological efficacy [60]. Commonly used vaccines promote antibody responses but have little

Hygiene hypothesis-link between gut microbiota and disease

Microorganisms colonising the human gastrointestinal tract are now recognized to contribute significantly to improved nutrient status and health of the host. These outcomes are achieved mainly through improved nutrient availability and nutrient capture in the human colon but also through enhanced immune functionality. Such positive effects on the immune system are though to confer protection against many human diseases including inflammatory bowel disease (IBD), atopic diseases and other

Hygiene hypothesis and the normal commensal microbiota

The hygiene hypothesis may be extended to encompass the protective effects of benign, non-infectious gut microbes. The basis of this assumption is that altered microbial diversity and functional activities of the luminal microbiota may be linked to the etiology of immune-mediated diseases. In children with allergic diseases, the fecal microbiota composition is markedly different from the norm. For example, the fecal microbiota of children with eczema is characterized by lower number of

Probiotic approaches to restore microbial balance and treat human diseases

Due to the potential beneficial effects of commensal bacteria on immune function, there is now considerable interest in using probiotics in clinical medicine for the treatment of a wide range of disorders including necrotizing enterocolitis in pre-term infants, atopic eczema, inflammatory bowel diseases and cancer (reviewed by [110], [111]). Some clinical trials suggest that probiotics exert either prophylactic or therapeutic benefit [112], [113] whereas others have shown that they have no

Summary

The functionally immature immune status of a newborn must be properly educated to deal with the challenges of autonomous life such as the development immune competence against pathogens, while ensuring that tolerance to common food antigens and commensal microbiota is maintained. Appropriate antigen exposure of the infant gut at the right time is crucial for the healthy development of gut-associated and systemic immune responses. This includes colonization of the gut by bacteria from the

Acknowledgements

The author's work was sponsored by the Scottish Executive Environment and Rural Affairs Department.

Reference (115)

  • A.J. Macpherson et al.

    IgA responses in the intestinal mucosa against pathogenic and non-pathogenic microorganisms

    Microbes Infect.

    (2001)
  • M.K. Bjursell et al.

    Functional genomic and metabolic studies of the adaptations of a prominent adult human gut symbiont, bacteroides thetaiotaomicron, to the suckling period

    J. Biol. Chem.

    (2006)
  • D. Kelly et al.

    Commensal gut bacteria: mechanisms of immune modulation

    Trends Immunol.

    (2005)
  • B. Pulendran et al.

    Translating innate immunity into immunological memory: implications for vaccine development

    Cell

    (2006)
  • D.N. Cook et al.

    CCR6 mediates dendritic cell localization, lymphocyte homeostasis, and immune responses in mucosal tissue

    Immunity

    (2000)
  • R. Medzhitov et al.

    Innate immunity: impact on the adaptive immune response

    Curr. Opin. Immunol.

    (1997)
  • M. Karin et al.

    Innate immunity gone awry: linking microbial infections to chronic inflammation and cancer

    Cell

    (2006)
  • J.F. Bach

    Infections and autoimmune diseases

    J. Autoimmun.

    (2005)
  • S. Rakoff-Nahoum et al.

    Role of toll-like receptors in spontaneous commensal-dependent colitis

    Immunity

    (2006)
  • J. Viala et al.

    Nods and ‘intracellular’ innate immunity

    C R Biol.

    (2004)
  • R. Yamada et al.

    Recent findings on genes associated with inflammatory disease

    Mutat. Res.

    (2005)
  • P.G. Falk et al.

    Creating and maintaining the gastrointestinal ecosystem: what we know and need to know from gnotobiology

    Microbiol. Mol. Biol. Rev.

    (1998)
  • S. Salminen et al.

    Functional food science and gastrointestinal physiology and function

    Br. J. Nutr.

    (1998)
  • F. Backhed et al.

    The gut microbiota as an environmental factor that regulates fat storage

    Proc. Natl. Acad. Sci. U.S.A.

    (2004)
  • R.E. Ley et al.

    Microbial ecology: human gut microbes associated with obesity

    Nature

    (2006)
  • P.J. Turnbaugh et al.

    An obesity-associated gut microbiome with increased capacity for energy harvest

    Nature

    (2006)
  • D. Kelly et al.

    Commensal anaerobic gut bacteria attenuate inflammation by regulating nuclear-cytoplasmic shuttling of PPAR-gamma and RelA

    Nat. Immunol.

    (2004)
  • T.S. Stappenbeck et al.

    Developmental regulation of intestinal angiogenesis by indigenous microbes via Paneth cells

    Proc. Natl. Acad. Sci. U.S.A.

    (2002)
  • C.O. Elson

    Animal models of experimental IBD: have they taught enough or do we need more?

    Inflamm. Bowel. Dis.

    (2006)
  • C.J. Bayne

    Origins and evolutionary relationships between the innate and adaptive arms of immune systems

    Integr. Comp. Biol.

    (2003)
  • G.L. Simon et al.

    The human intestinal microflora

    Dig. Dis. Sci.

    (1986)
  • D.C. Savage

    Microbial ecology of the gastrointestinal tract

    Annu. Rev. Microbiol.

    (1977)
  • K.H. Wilson et al.

    Human colonic biota studied by ribosomal DNA sequence analysis

    Appl. Environ. Microbiol.

    (1996)
  • A. Suau et al.

    Direct analysis of genes encoding 16S rRNA from complex communities reveals many novel molecular species within the human gut

    Appl. Environ. Microbiol.

    (1999)
  • P.B. Eckburg et al.

    Diversity of the human intestinal microbial flora

    Science

    (2005)
  • P.S. Langendijk et al.

    Quantitative fluorescence in situ hybridization of Bifidobacterium spp. with genus-specific 16S rRNA-targeted probes and its application in fecal samples

    Appl. Environ. Microbiol.

    (1995)
  • A.H. Franks et al.

    Variations of bacterial populations in human feces measured by fluorescent in situ hybridization with group-specific 16S rRNA-targeted oligonucleotide probes

    Appl. Environ. Microbiol.

    (1998)
  • E.G. Zoetendal et al.

    Quantification of uncultured Ruminococcus obeum-like bacteria in human fecal samples by fluorescent in situ hybridization and flow cytometry using 16S rRNA-targeted probes

    Appl. Environ. Microbiol.

    (2002)
  • S. Fanaro et al.

    Intestinal microflora in early infancy: composition and development

    Acta Paediatr.

    (2003)
  • C.L. Bullen et al.

    Bifidobacteria in the intestinal tract of infants: an in-vivo study

    J. Med. Microbiol.

    (1976)
  • J. Penders et al.

    Factors influencing the composition of the intestinal microbiota in early infancy

    Pediatrics

    (2006)
  • A. Hirai et al.

    Palladium-catalyzed stereospecific epoxide-opening reaction of gamma, delta-epoxy-alpha, beta-unsaturated esters with an alkylboronic acid leading to gamma, delta-vicinal diols with double inversion of the configuration

    Chem. Commun. (Camb.)

    (2003)
  • F. Smaill

    Antibiotic prophylaxis and caesarean section

    Br. J. Obstet. Gynaecol.

    (1992)
  • M.M. Gronlund et al.

    Fecal microflora in healthy infants born by different methods of delivery: permanent changes in intestinal flora after cesarean delivery

    J. Pediatr. Gastroenterol. Nutr.

    (1999)
  • J. Kero et al.

    Mode of delivery and asthma—is there a connection?

    Pediatr. Res.

    (2002)
  • H. Renz-Polster et al.

    Caesarean section delivery and the risk of allergic disorders in childhood

    Clin. Exp. Allergy

    (2005)
  • I. Adlerberth et al.

    Reduced enterobacterial and increased staphylococcal colonization of the infantile bowel: an effect of hygienic lifestyle?

    Pediatr. Res.

    (2006)
  • G.W. Tannock

    Normal Microflora: An Introduction to Microbes Inhabiting the Human Body

    (1995)
  • P. Marteau et al.

    Comparative study of bacterial groups within the human cecal and fecal microbiota

    Appl. Environ. Microbiol.

    (2001)
  • H. Hayashi et al.

    Molecular analysis of jejunal, ileal, caecal and recto-sigmoidal human colonic microbiota using 16S rRNA gene libraries and terminal restriction fragment length polymorphism

    J. Med. Microbiol.

    (2005)
  • Cited by (0)

    View full text